Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Virtual Booth

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 350992-13-1, Bifeprunox mesilate, Du-127090, Du127090, Bifeprunox mesylate [usan], Bifeprunox (mesylate)

Molecular Formula

C₂₅H₂₇N₃O₅S

Molecular Weight

481.6 g/mol

InChI Key

ONWKHSGOYGLGPO-UHFFFAOYSA-N

FDA UNII

8F018D8L02

1 2D Structure

Bifeprunox

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

methanesulfonic acid;7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-one

2.1.2 InChI

InChI=1S/C24H23N3O2.CH4O3S/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19;1-5(2,3)4/h1-11,16H,12-15,17H2,(H,25,28);1H3,(H,2,3,4)

2.1.3 InChI Key

ONWKHSGOYGLGPO-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CS(=O)(=O)O.C1CN(CCN1CC2=CC(=CC=C2)C3=CC=CC=C3)C4=CC=CC5=C4OC(=O)N5

2.2 Other Identifiers

2.2.1 UNII

8F018D8L02

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Bifeprunox

2. Bifeprunox Mesilate

3. Du-127090

4. Du127090

2.3.2 Depositor-Supplied Synonyms

1. 350992-13-1

2. Bifeprunox Mesilate

3. Du-127090

4. Du127090

5. Bifeprunox Mesylate [usan]

6. Bifeprunox (mesylate)

7. 350992-13-1 (mesylate)

8. Bifeprunox Methanesulfonate

9. 7-(4-(biphenyl-3-ylmethyl)piperazin-1-yl)benzoxazol-2(3h)-one Methanesulfonate

10. 8f018d8l02

11. Bifeprunox Mesylate (usan)

12. 2(3h)-benzoxazolone, 7-(4-((1,1'-biphenyl)-3-ylmethyl)-1-piperazinyl)-, Monomethanesulfonate

13. Du 127090

14. Unii-8f018d8l02

15. Methanesulfonic Acid;7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3h-1,3-benzoxazol-2-one

16. Schembl1248663

17. Chembl2107317

18. Dtxsid00956533

19. Bcp02133

20. Bifeprunox Mesylate [who-dd]

21. Akos030254375

22. Bifeprunox Mesylate, >=98% (hplc)

23. 7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3h)-benzoxazolone Monomethanesulfonate

24. Bifeprunox Methanesulfonate [mi]

25. Ft-0663112

26. A14091

27. D06567

28. E98792

29. A929992

30. J-019873

31. Q27270277

32. 7-(4-(biphenyl-3-ylmethyl)piperazin-1-yl)benzoxazol-2(3h)-one Methanesulphonate

33. 2(3h)-benzoxazolone, 7-(4-((1,1'-biphenyl)-3-ylmethyl)-1-piperazinyl)-, Monomethanesulphonate

34. Methanesulfonic Acid--7-{4-[([1,1'-biphenyl]-3-yl)methyl]piperazin-1-yl}-1,3-benzoxazol-2-ol (1/1)

2.4 Create Date

2006-07-28

3 Chemical and Physical Properties

Molecular Formula	C₂₅H₂₇N₃O₅S
Molecular Weight	481.6 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	4
Exact Mass	481.16714214 g/mol
Monoisotopic Mass	481.16714214 g/mol
Topological Polar Surface Area	108 Å²
Heavy Atom Count	34
Formal Charge	0
Complexity	649
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2